Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Rafferty
Ian Miller
Conrad Timon

Showing results (161-170 of 180) with videos related to

Pageof 18
Sort By:
Epilepsia|May 4, 2021
Evaluation of diazepam nasal spray in patients with epilepsy concomitantly using maintenance benzodiazepines: An interim subgroup analysis from a phase 3, long-term, open-label safety studyEric B Segal, Daniel Tarquinio, Ian Miller, et al.
Epilepsia|April 20, 2022
A randomized, double-blind trial of triheptanoin for drug-resistant epilepsy in glucose transporter 1 deficiency syndromePasquale Striano, Stéphane Auvin, Abigail Collins, et al.
British Journal of Haematology|April 2, 2020
Outcomes of older patients with primary central nervous system lymphoma treated in routine clinical practice in the UK: methotrexate dose intensity correlates with response and survivalNicolás Martinez-Calle, Edward Poynton, Alia Alchawaf, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 10, 2024
Triheptanoin Did Not Show Benefit versus Placebo for the Treatment of Paroxysmal Movement Disorders in Glut1 Deficiency Syndrome: Results of a Randomized Phase 3 StudyValentina De Giorgis, Kailash P Bhatia, Odile Boespflug-Tanguy, et al.
Lancet (London, England)|December 22, 2019
Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trialLieven Lagae, Joseph Sullivan, Kelly Knupp, et al.
The Lancet. Neurology|January 3, 2016
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trialOrrin Devinsky, Eric Marsh, Daniel Friedman, et al.
Journal of the American Academy of Dermatology|February 14, 2026
Avapritinib improves cutaneous involvement in patients with indolent systemic mastocytosis: Results from the randomized, phase 2, interventional PIONEER studyFrank Siebenhaar, Sigurd Broesby-Olsen, Mariana Castells, et al.
Seizure|August 18, 2018
Presurgical hyperconnectivity of the ablation volume is associated with seizure-freedom after magnetic resonance-guided laser interstitial thermal therapyGeorge M Ibrahim, Alexander G Weil, Shaina Sedighim, et al.
Epilepsia|October 6, 2015
Diagnostic methods and treatment options for focal cortical dysplasiaRenzo Guerrini, Michael Duchowny, Prasanna Jayakar, et al.
Nature Chemical Biology|February 5, 2021
Phospholipase iPLA<sub>2</sub>β averts ferroptosis by eliminating a redox lipid death signalWan-Yang Sun, Vladimir A Tyurin, Karolina Mikulska-Ruminska, et al.
Pageof 18

Showing results (161-170 of 180) with videos related to

Sort By:
Pageof 18
Epilepsia|May 4, 2021
Evaluation of diazepam nasal spray in patients with epilepsy concomitantly using maintenance benzodiazepines: An interim subgroup analysis from a phase 3, long-term, open-label safety studyEric B Segal, Daniel Tarquinio, Ian Miller, et al.
Epilepsia|April 20, 2022
A randomized, double-blind trial of triheptanoin for drug-resistant epilepsy in glucose transporter 1 deficiency syndromePasquale Striano, Stéphane Auvin, Abigail Collins, et al.
British Journal of Haematology|April 2, 2020
Outcomes of older patients with primary central nervous system lymphoma treated in routine clinical practice in the UK: methotrexate dose intensity correlates with response and survivalNicolás Martinez-Calle, Edward Poynton, Alia Alchawaf, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 10, 2024
Triheptanoin Did Not Show Benefit versus Placebo for the Treatment of Paroxysmal Movement Disorders in Glut1 Deficiency Syndrome: Results of a Randomized Phase 3 StudyValentina De Giorgis, Kailash P Bhatia, Odile Boespflug-Tanguy, et al.
Lancet (London, England)|December 22, 2019
Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trialLieven Lagae, Joseph Sullivan, Kelly Knupp, et al.
The Lancet. Neurology|January 3, 2016
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trialOrrin Devinsky, Eric Marsh, Daniel Friedman, et al.
Journal of the American Academy of Dermatology|February 14, 2026
Avapritinib improves cutaneous involvement in patients with indolent systemic mastocytosis: Results from the randomized, phase 2, interventional PIONEER studyFrank Siebenhaar, Sigurd Broesby-Olsen, Mariana Castells, et al.
Seizure|August 18, 2018
Presurgical hyperconnectivity of the ablation volume is associated with seizure-freedom after magnetic resonance-guided laser interstitial thermal therapyGeorge M Ibrahim, Alexander G Weil, Shaina Sedighim, et al.
Epilepsia|October 6, 2015
Diagnostic methods and treatment options for focal cortical dysplasiaRenzo Guerrini, Michael Duchowny, Prasanna Jayakar, et al.
Nature Chemical Biology|February 5, 2021
Phospholipase iPLA<sub>2</sub>β averts ferroptosis by eliminating a redox lipid death signalWan-Yang Sun, Vladimir A Tyurin, Karolina Mikulska-Ruminska, et al.
Pageof 18